Arginine deiminase-polymeric hybrid nanoconjugates: A potential biodrug for targeted treatment of arginine auxotrophic cancers - ScienceDirect.com
  Bio-S: a unique facility in Europe for the clinical manufacture of new biodrugs - Servier
  Windward Bio: Drug Development Company Raises $200 Million (Series A) - Pulse 2.0
  Solve FSHD supports Armatus Bio drug for facioscapulohumeral muscular dystrophy - BioWorld MedTech
  Longan-inspired chitosan-pectin core-shell hydrogel beads for oral delivery of biodrugs to enhance osteoporosis therapy - ScienceDirect.com
  Toward therapeutic progress with Bio-S, our first bioproduction unit - Servier
  Dash Bio: Drug Development Company Secures $6.5 Million (Seed) - Pulse 2.0
  AGC Biologics and BioConnection Partner to Offer Biodrug Product Development and Manufacturing - Genetic Engineering and Biotechnology News